Article,

A Randomized, Multicenter, Open-Label Clinical Trial to Assess the Immunogenicity of a Meningococcal C Vaccine Booster Dose Administered to Children Aged 14 to 18 Months

, , , , , , , , and .
The Pediatric Infectious Disease Journal, 29 (2): 148--152 (2010)
DOI: 10.1097/INF.0b013e3181b9a831